Shilpa H Jain, MD | UniHealth

Offices

1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Hospitals listed: California Pacific Medical Center- Van Ness Campus. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Jain’s office at (415) 600-0110 to ask if they take your plan before you enroll.

California Medical Board record

Licence A107201 · Current

Licensed to practise in California · since 2009 · expires 2027-01-31 · Mount Sinai School of Medicine of New York University.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend it
Overall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025

See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at California Pacific Medical Center- Van Ness Campus

Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.224	Better	Oct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.325	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.373	Better	Oct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.14 (0.3 to 1.97) · 2,271 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	1.05 (0.81 to 1.28)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	192.86 (151.51 to 234.22) · 140 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	2.6 · 55 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	10.3 · 60 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	10.5 · 143 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	9.8 · 356 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	14.3 · 259 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	10.1 · 173 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	3.1 · 2,316 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.31 (0.12 to 0.49) · 6,430 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.09 to 0.47) · 7,168 cases	No different	Jul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	3.3 (1.5 to 5.09) · 2,196 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	2.47 (1.21 to 3.74) · 925 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.63 (1.37 to 3.88) · 1,954 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	10.13 (6.06 to 14.2) · 1,112 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	7.26 (4.67 to 9.85) · 1,084 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.67 (0.31 to 3.03) · 832 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.33 (0 to 0.85) · 5,406 cases	No different	Jul 2022 – Jun 2024
MRSA BacteremiaInfections	0.443	No different	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	1.717	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	14.3 · 200 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	22.3 · 449 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	18.2 · 187 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	8.7 · 418 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	7.1 · 260 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	19.2 · 293 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (3.6 to 7.6) · 157 cases	No different	Jan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	10.2 (7.7 to 13.5) · 157 cases	No different	Jan 2024 – Dec 2024
Rate of readmission for CABGUnplanned return visits	11 · 33 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	20.2 · 66 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.5 (9.4 to 16.7) · 551 cases	No different	Jan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.9 (0.7 to 1.3) · 219 cases	No different	Jan 2024 – Dec 2024

What patients said (478 patients answered, 20% of those asked)

Sort by

Patient survey stars by topic at California Pacific Medical Center- Van Ness Campus

Cleanliness	4
Nurse communication	3
Doctor communication	3
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	3
Recommend hospital	5

Sort by

Share of patients giving the best answer at California Pacific Medical Center- Van Ness Campus

Room was "always" clean	75%
Nurses "always" communicated well	74%
Doctors "always" communicated well	77%
Staff "always" explained	59%
Yes, staff "did" give patients this information	88%
Yes, staff "did" give patients information about help after discharge	88%
Doctors "always" explained things so they could understand	71%
Doctors "always" listened carefully	75%
Doctors "always" treated them with courtesy and respect	85%
Patients who gave a rating of "9" or "10" (high)	75%
Staff "always" explained new medications	75%
Nurses "always" explained things so they could understand	70%
Nurses "always" listened carefully	71%
Nurses "always" treated them with courtesy and respect	82%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	78%
Staff "always" explained possible side effects	44%
Yes, staff "did" give patients information about possible symptoms	88%

Original Medicare doctor bills

$40,160

Medicare paid this office $40,160 for 198 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Return visit (30+ min)	122	$18,708	$105
Diabetes outpatient self-management training services, individual, per 30 minutes	37	$4,514	$48
New patient visit (60+ min)	18	$3,244	$180
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	121	$2,347	$14
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	12	$2,296	$70

See all 9 services

Sort by

Every Original Medicare service billed

Return visit (30+ min)	122	$18,708	$105
Diabetes outpatient self-management training services, individual, per 30 minutes	37	$4,514	$48
New patient visit (60+ min)	18	$3,244	$180
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	121	$2,347	$14
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	12	$2,296	$70
Long return visit (40+ min)	14	$2,178	$156
New patient visit (45+ min)	15	$2,144	$143
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	21	$999	$31
Hemoglobin a1c level	38	$457	$10

Who their Medicare patients are

198 Original Medicare patients in 2024. Average age 71 · Under 65 12% · 85 and older 7% · Women 64% · Also on Medicaid 23% · Health risk score 1.53. Above the middle of the specialty; the typical endocrinology clinician is at 1.46.

Conditions among them: High blood pressure 70% · Diabetes 55% · Chronic kidney disease 35% · Depression 31% · Coronary heart disease 22% · Atrial fibrillation 17% · Heart failure 16% · Cancer 14% · COPD 8% · Stroke 8% · Dementia 6%.

The office billed $152,874, Medicare allowed $55,299 and paid $40,160; for 644 services of 19 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	198	644	71	1.53	$152,874	$40,160
2023	167	400	71	1.33	$110,615	$30,637
2022	171	985	70	1.38	$133,256	$40,251
2021	163	456	70	1.19	$127,492	$37,789
2020	143	550	69	1.52	$118,815	$29,227
2019	152	563	69	1.39	$134,535	$33,754
2018	117	329	68	1.57	$99,344	$23,995
2017	102	308	68	1.56	$93,471	$24,043
2016	86	215	68	2.20	$79,175	$20,684
2015	33	56	66	2.28	$22,255	$5,850

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 7 services

Sort by

Original Medicare services billed in 2023

Return visit (30+ min)	103	$14,550	$102
New patient visit (60+ min)	24	$4,663	$194
Diabetes outpatient self-management training services, individual, per 30 minutes	25	$2,849	$49
Long return visit (40+ min)	11	$1,882	$157
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	11	$1,436	$72
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	11	$537	$30
Hemoglobin a1c level	31	$352	$10

2022: 7 services

Sort by

Original Medicare services billed in 2022

Return visit (30+ min)	117	$20,473	$104
Long return visit (40+ min)	22	$3,683	$153
Diabetes outpatient self-management training services, individual, per 30 minutes	27	$3,421	$50
New patient visit (60+ min)	16	$2,962	$185
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	17	$888	$32
Hemoglobin a1c level	45	$614	$10
Blood glucose (sugar) test performed by hand-held instrument	11	$42	$3

2021: 7 services

Sort by

Original Medicare services billed in 2021

Return visit (30+ min)	105	$20,165	$107
Long return visit (40+ min)	34	$6,452	$157
Diabetes outpatient self-management training services, individual, per 30 minutes	30	$3,747	$51
New patient visit (60+ min)	19	$3,449	$182
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	21	$1,357	$32
Hemoglobin a1c level	30	$437	$10
Blood glucose (sugar) test performed by hand-held instrument	14	$52	$3

2020: 6 services

Sort by

Original Medicare services billed in 2020

Return visit (30+ min)	100	$14,925	$84
Initial hospital care with moderate level of medical decision making at least 75 minutes	11	$2,026	$184
New patient visit (45+ min)	13	$1,691	$130
New patient visit (60+ min)	11	$1,585	$144
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	12	$589	$29
Hemoglobin a1c level	32	$365	$10

2019: 6 services

Sort by

Original Medicare services billed in 2019

Return visit (30+ min)	91	$16,237	$89
Diabetes outpatient self-management training services, individual, per 30 minutes	29	$6,254	$49
New patient visit (60+ min)	16	$2,850	$178
New patient visit (45+ min)	19	$2,418	$127
Hemoglobin a1c level	41	$655	$11
Blood glucose (sugar) test performed by hand-held instrument	18	$64	$3

2018: 6 services

Sort by

Original Medicare services billed in 2018

Return visit (30+ min)	74	$11,815	$85
New patient visit (45+ min)	20	$2,399	$120
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	11	$2,393	$65
New patient visit (60+ min)	11	$1,893	$172
Hemoglobin a1c level	28	$470	$12
Blood glucose (sugar) test performed by hand-held instrument	13	$55	$3

2017: 5 services

Sort by

Original Medicare services billed in 2017

Return visit (30+ min)	63	$12,378	$89
New patient visit (45+ min)	31	$4,567	$147
New patient visit (60+ min)	17	$2,344	$138
Hemoglobin a1c level	24	$587	$13
Blood glucose (sugar) test performed by hand-held instrument	13	$57	$3

2016: 6 services

Sort by

Original Medicare services billed in 2016

Return visit (30+ min)	36	$7,109	$95
New patient visit (45+ min)	19	$2,925	$154
New patient visit (60+ min)	17	$2,804	$165
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	14	$1,941	$65
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	15	$1,712	$114
Hemoglobin a1c level	12	$220	$13

2015: 1 service

Sort by

Original Medicare services billed in 2015

Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	11	$1,044	$65

Medicaid work

$2,953 in 2024

Medicaid paid $2,953 for 85 billed services this clinician did in 2024, up to 20 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2024

Return visit (30+ min)	85	$2,953

Sort by

Medicaid work by year

2024	85	1	20	$2,953
2022	12	1	12	$64
2021	16	1	15	$171
2020	27	1	15	$714
2019	92	2	16	$3,593
2018	149	2	19	$6,836

See the largest Medicaid services in earlier years

2022

Sort by

Largest Medicaid services in 2022

Return visit (30+ min)	12	$64

2021

Sort by

Largest Medicaid services in 2021

Return visit (30+ min)	16	$171

2020

Sort by

Largest Medicaid services in 2020

Return visit (30+ min)	27	$714

2019

Sort by

Largest Medicaid services in 2019

Diabetes outpatient self-management training services, individual, per 30 minutes	39	$1,945
Return visit (30+ min)	53	$1,649

2018

Sort by

Largest Medicaid services in 2018

Diabetes outpatient self-management training services, individual, per 30 minutes	89	$4,836
Return visit (30+ min)	60	$2,000

Drugs they prescribed that Part D paid

$730,994

Pharmacies billed $730,994 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 1,443) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.

558 generic and 798 brand-name prescriptions · $730,994 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Ozempic	213	$238,525	$1,120
Jardiance	125	$127,210	$1,018
Mounjaro	102	$125,909	$1,234
Januvia	42	$48,962	$1,166
Trulicity	17	$27,499	$1,618

See all 28 drugs

Sort by

Every Part D drug this clinician prescribed

Ozempic	213	$238,525	$1,120
Jardiance	125	$127,210	$1,018
Mounjaro	102	$125,909	$1,234
Januvia	42	$48,962	$1,166
Trulicity	17	$27,499	$1,618
Wegovy	14	$18,615	$1,330
Tradjenta	12	$16,971	$1,414
Lyumjev	11	$13,940	$1,267
Humalog Kwikpen U-100	36	$7,270	$202
Basaglar Kwikpen U-100	19	$6,644	$350
Lantus Solostar	46	$6,269	$136
Tirosint	20	$4,330	$217
Nano 2nd Gen Pen Needle	36	$3,389	$94
Synthroid	23	$1,817	$79
Metformin Hcl Er	88	$1,624	$18
Levothyroxine	114	$1,489	$13
Ultra-Fine Short Pen Needle	16	$1,378	$86
Metformin	55	$500	$9
Alendronate	49	$464	$9
Atorvastatin	45	$451	$10
Glipizide Er	21	$410	$20
Pioglitazone	12	$361	$30
Methimazole	26	$353	$14
Lisinopril	37	$271	$7
Glipizide	23	$251	$11
Naltrexone	12	$201	$17
Losartan	16	$112	$7
Amlodipine Besylate	19	$40	$2

Year by year

Sort by

Part D prescribing by year

2024	1,443	164	0% (0)	55%	$730,994
2023	1,391	142	0% (0)	56%	$832,796
2022	1,318	148	0% (0)	56%	$745,838
2021	1,392	138	0% (0)	52%	$607,417
2020	1,265	130	0% (0)	50%	$502,248
2019	1,079	120	0% (0)	47%	$383,803
2018	865	101	0% (0)	43%	$243,893
2017	568	68	0% (0)	41%	$127,706
2016	167	37	0% (0)	35%	$31,571
2015	18	None	0% (0)	None	$542

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 24 drugs

Sort by

Part D drugs prescribed in 2023

Ozempic	161	$216,578	$1,345
Jardiance	142	$142,910	$1,006
Mounjaro	104	$120,353	$1,157
Trulicity	56	$74,903	$1,338
Januvia	42	$61,275	$1,459
Lantus Solostar	52	$39,200	$754
Humalog Kwikpen U-100	32	$28,150	$880
Basaglar Kwikpen U-100	24	$7,402	$308
Nano 2nd Gen Pen Needle	47	$4,461	$95
Synthroid	19	$2,299	$121
Ultra-Fine Short Pen Needle	15	$1,797	$120
Metformin Hcl Er	73	$1,582	$22
Levothyroxine	101	$1,466	$15
Atorvastatin	56	$950	$17
Metformin	45	$599	$13
Lisinopril	38	$586	$15
Glipizide Er	18	$542	$30
Alendronate	42	$528	$13
Methimazole	26	$464	$18
Naltrexone	17	$414	$24
Losartan	20	$378	$19
Glipizide	27	$366	$14
Amlodipine Besylate	21	$269	$13
Rosuvastatin	12	$236	$20

2022: 28 drugs

Sort by

Part D drugs prescribed in 2022

Ozempic	98	$156,430	$1,596
Jardiance	116	$114,680	$989
Trulicity	61	$76,877	$1,260
Victoza 3-Pak	33	$65,966	$1,999
Januvia	34	$50,407	$1,483
Mounjaro	34	$46,193	$1,359
Lantus Solostar	44	$33,506	$762
Humalog Kwikpen U-100	37	$27,886	$754
Tradjenta	11	$14,655	$1,332
Novolog Flexpen	17	$13,923	$819
Humalog	14	$12,987	$928
Basaglar Kwikpen U-100	37	$12,461	$337
Tresiba Flextouch U-100	13	$5,750	$442
Nano 2nd Gen Pen Needle	53	$5,207	$98
Synthroid	28	$2,474	$88
Insulin Lispro Kwikpen U-100	12	$2,027	$169
Levothyroxine	97	$1,614	$17
Metformin Hcl Er	68	$1,390	$20
Naltrexone	15	$1,030	$69
Atorvastatin	41	$595	$15
Metformin	48	$543	$11
Alendronate	41	$535	$13
Glipizide Er	19	$489	$26
Methimazole	31	$369	$12
Lisinopril	35	$351	$10
Glipizide	31	$344	$11
Losartan	21	$278	$13
Amlodipine Besylate	33	$156	$5

2021: 29 drugs

Sort by

Part D drugs prescribed in 2021

Trulicity	90	$101,469	$1,127
Jardiance	119	$93,645	$787
Ozempic	37	$63,634	$1,720
Victoza 3-Pak	33	$53,562	$1,623
Januvia	31	$45,504	$1,468
Lantus Solostar	61	$40,448	$663
Humalog Kwikpen U-100	34	$28,899	$850
Tresiba Flextouch U-200	16	$20,293	$1,268
Novolog Flexpen	19	$15,005	$790
Novolog	12	$12,851	$1,071
Basaglar Kwikpen U-100	29	$10,067	$347
Nano 2nd Gen Pen Needle	35	$3,120	$89
Insulin Lispro Kwikpen U-100	12	$3,102	$259
Levothyroxine	121	$2,350	$19
Synthroid	30	$1,482	$49
Metformin Hcl Er	82	$1,269	$15
Naltrexone	22	$856	$39
Alendronate	43	$652	$15
Metformin	61	$588	$10
Atorvastatin	48	$547	$11
Glipizide Er	25	$488	$20
Methimazole	32	$457	$14
Lisinopril	35	$350	$10
Glipizide	40	$301	$8
Pioglitazone	15	$266	$18
Losartan	23	$244	$11
Levoxyl	11	$241	$22
Amlodipine Besylate	45	$156	$3
Alcohol Prep Pads	11	$44	$4

2020: 30 drugs

Sort by

Part D drugs prescribed in 2020

Victoza 3-Pak	39	$70,031	$1,796
Trulicity	72	$64,157	$891
Jardiance	89	$63,417	$713
Ozempic	33	$32,823	$995
Humalog Kwikpen U-100	36	$32,543	$904
Januvia	22	$27,491	$1,250
Lantus Solostar	52	$25,327	$487
Humalog	12	$10,714	$893
Basaglar Kwikpen U-100	25	$9,657	$386
Tradjenta	11	$9,404	$855
Novolog Flexpen	12	$9,103	$759
Novolog	11	$8,910	$810
Ultra-Fine Nano Pen Needle	41	$3,170	$77
Synthroid	38	$1,747	$46
Levothyroxine	83	$1,632	$20
Metformin Hcl Er	72	$1,380	$19
Naltrexone	20	$947	$47
Potassium Citrate Er	11	$867	$79
Alendronate	53	$738	$14
Methimazole	41	$581	$14
Metformin	58	$576	$10
Glipizide Er	13	$528	$41
Atorvastatin	29	$370	$13
Levoxyl	12	$328	$27
Pioglitazone	18	$307	$17
Losartan	15	$275	$18
Glipizide	35	$252	$7
Lisinopril	17	$138	$8
Amlodipine Besylate	48	$120	$3
Alcohol Prep Pads	12	$25	$2

2019: 25 drugs

Sort by

Part D drugs prescribed in 2019

Victoza 3-Pak	50	$62,292	$1,246
Trulicity	66	$58,407	$885
Forteo	13	$47,302	$3,639
Jardiance	45	$33,971	$755
Humalog Kwikpen U-100	40	$29,602	$740
Lantus Solostar	56	$24,870	$444
Januvia	17	$22,339	$1,314
Basaglar Kwikpen U-100	29	$13,069	$451
Tradjenta	13	$5,650	$435
Ultra-Fine Nano Pen Needle	33	$2,043	$62
Metformin Hcl Er	71	$1,616	$23
Levothyroxine	75	$1,389	$19
Ultra-Fine Mini Pen Needle	11	$1,073	$98
Synthroid	23	$932	$41
Methimazole	57	$714	$13
Naltrexone	29	$581	$20
Pioglitazone	17	$578	$34
Alendronate	49	$541	$11
Glimepiride	22	$477	$22
Atorvastatin	22	$439	$20
Metformin	54	$376	$7
Bupropion Xl	12	$312	$26
Glipizide	35	$246	$7
Amlodipine Besylate	30	$113	$4
Lisinopril	18	$100	$6

2018: 23 drugs

Sort by

Part D drugs prescribed in 2018

Trulicity	33	$35,380	$1,072
Victoza 3-Pak	25	$27,836	$1,113
Humalog Kwikpen U-100	28	$25,128	$897
Januvia	22	$21,177	$963
Basaglar Kwikpen U-100	42	$19,281	$459
Jardiance	26	$18,933	$728
Lantus Solostar	44	$17,998	$409
Victoza 2-Pak	14	$12,927	$923
Tradjenta	12	$4,997	$416
Ultra-Fine Nano Pen Needle	43	$2,514	$58
Levothyroxine	71	$1,111	$16
Ultra-Fine Mini Pen Needle	13	$925	$71
Metformin Hcl Er	77	$868	$11
Metformin	62	$427	$7
Methimazole	40	$381	$10
Alendronate	46	$379	$8
Glimepiride	13	$271	$21
Naltrexone	12	$222	$19
Glipizide Er	15	$206	$14
Glipizide	29	$131	$5
Atorvastatin	12	$123	$10
Lisinopril	12	$95	$8
Amlodipine Besylate	28	$49	$2

2017: 23 drugs

Sort by

Part D drugs prescribed in 2017

Trulicity	23	$24,142	$1,050
Lantus Solostar	37	$16,596	$449
Januvia	19	$14,574	$767
Humalog Kwikpen U-100	14	$13,993	$999
Victoza 3-Pak	12	$9,685	$807
Bydureon	13	$8,053	$619
Tradjenta	14	$5,423	$387
Cabergoline	12	$2,268	$189
Ultra-Fine Nano Pen Needle	29	$1,454	$50
Levothyroxine	57	$1,089	$19
Ultra-Fine Mini Pen Needle	11	$556	$51
Metformin Hcl Er	38	$400	$11
Pravastatin	11	$352	$32
Atorvastatin	14	$248	$18
Alendronate	23	$237	$10
Glipizide Er	20	$215	$11
Methimazole	16	$201	$13
Liothyronine	11	$179	$16
Metformin	27	$116	$4
Lisinopril	11	$79	$7
Glimepiride	14	$65	$5
Glipizide	15	$53	$4
Amlodipine Besylate	22	$43	$2

2016: 5 drugs

Sort by

Part D drugs prescribed in 2016

Lantus Solostar	15	$6,811	$454
Bd Ultra-Fine Pen Needle	11	$417	$38
Methimazole	20	$354	$18
Levothyroxine	17	$232	$14
Alendronate	11	$53	$5

Money from drug and device companies

$85 in 2025

Sort by

Industry payments by year

2025	2	2	None	$85
2024	3	3	None	$77
2023	2	4	None	$136
2022	3	3	None	$84
2021	1	1	None	$21
2020	2	9	None	$167
2019	5	6	None	$226

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Soleno Therapeutics	Vykat Xr	$58	1 payment Meals for Vykat Xr · 2025-07-13 · $58
Sequel Med Tech	Twiist	$27	1 payment Meals for Twiist · 2025-03-18 · $27

See all 2 published payments

Sort by

Every published payment

Soleno Therapeutics	Meals · 2025-07-13	Vykat Xr	$58
Sequel Med Tech	Meals · 2025-03-18	Twiist	$27

See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $77

Sort by

Payments by company in 2024

Ipsen Biopharmaceuticals	Iqirvo	$34	1 payment Meals for Iqirvo · 2024-10-10 · $34
Tandem Diabetes Care	T:Slim X2 Insulin Pump With Control-Iq	$23	1 payment Meals for T:Slim X2 Insulin Pump With Control-Iq · 2024-03-17 · $23
Dexcom	Dexcom G6 Transmitter	$21	1 payment Meals for Dexcom G6 Transmitter · 2024-10-08 · $21

2023: $136

Sort by

Payments by company in 2023

Currax Pharmaceuticals	Nexletol	$75	3 payments Education for Nexletol · 2023-11-10 · $25 Education for Nexletol · 2023-11-10 · $25 Education for Nexletol · 2023-08-04 · $25
Medtronic	Minimed 780g	$61	1 payment Meals for Minimed 780g · 2023-06-21 · $61

2022: $84

Sort by

Payments by company in 2022

Horizon Therapeutics plc	Tepezza	$53	1 payment Meals for Tepezza · 2022-08-23 · $53
Insulet	Omnipod	$19	1 payment Meals for Omnipod · 2022-03-22 · $19
Lilly USA	None	$12	1 payment Education · 2022-06-28 · $12

2021: $21

Sort by

Payments by company in 2021

MannKind	Afrezza	$21	1 payment Meals for Afrezza · 2021-10-06 · $21

2020: $167

Sort by

Payments by company in 2020

AbbVie	Humira	$146	8 payments Meals for Humira · 2020-11-17 · $20 Meals for Humira · 2020-10-06 · $12 Meals for Humira · 2020-09-29 · $14 Meals for Humira · 2020-08-26 · $25 Meals for Humira · 2020-06-17 · $24 Meals for Humira · 2020-03-09 · $7 Meals for Humira · 2020-01-29 · $21 Meals for Humira · 2020-01-15 · $22
Takeda Pharmaceuticals U.S.A.	Entyvio	$22	1 payment Meals for Entyvio · 2020-02-19 · $22

2019: $226

Sort by

Payments by company in 2019

Novo Nordisk	Saxenda	$110	1 payment Meals for Saxenda · 2019-03-27 · $110
Insulet	Omnipod	$42	2 payments Meals for Omnipod · 2019-10-02 · $24 Meals for Omnipod · 2019-03-07 · $17
Dexcom	Dexcom Cgm	$28	1 payment Meals for Dexcom Cgm · 2019-10-02 · $28
Lilly USA	Baqsimi	$24	1 payment Meals for Baqsimi · 2019-08-30 · $24
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)	Lifevest	$22	1 payment Meals for Lifevest · 2019-12-19 · $22

Professional record

NPI: 1851369847
Licence: CA A107201California A107201: Current · expires 2027-01-31
Trained: Icahn School of Medicine at Mount Sinai, 2003
Group: Sutter Bay Medical Foundation
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207RE0101X (207RE0101X)
Mailing address: 1013 Castro St, San Francisco, CA, 94114
NPI first listed: 2006-03-08
NPI last updated: 2013-12-02

This is when the NPI record was last certified, not a medical board exam.